Private Trust Co. NA Grows Stock Position in The Cooper Companies, Inc. $COO

Private Trust Co. NA boosted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 25.2% in the 2nd quarter, HoldingsChannel reports. The fund owned 1,278 shares of the medical device company’s stock after buying an additional 257 shares during the quarter. Private Trust Co. NA’s holdings in Cooper Companies were worth $91,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of the stock. Horizon Investments LLC grew its holdings in shares of Cooper Companies by 5.0% in the first quarter. Horizon Investments LLC now owns 2,859 shares of the medical device company’s stock worth $241,000 after purchasing an additional 136 shares during the last quarter. Axxcess Wealth Management LLC boosted its position in Cooper Companies by 1.9% during the 1st quarter. Axxcess Wealth Management LLC now owns 7,382 shares of the medical device company’s stock valued at $623,000 after buying an additional 140 shares during the period. Wealth Alliance LLC grew its holdings in Cooper Companies by 5.5% in the 1st quarter. Wealth Alliance LLC now owns 4,059 shares of the medical device company’s stock worth $342,000 after acquiring an additional 210 shares during the last quarter. EverSource Wealth Advisors LLC increased its position in shares of Cooper Companies by 3.5% in the first quarter. EverSource Wealth Advisors LLC now owns 6,517 shares of the medical device company’s stock valued at $550,000 after acquiring an additional 220 shares during the period. Finally, Hardy Reed LLC increased its position in shares of Cooper Companies by 4.1% in the second quarter. Hardy Reed LLC now owns 6,213 shares of the medical device company’s stock valued at $442,000 after acquiring an additional 244 shares during the period. 24.39% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, CEO Albert G. White III purchased 10,000 shares of the stock in a transaction dated Friday, September 5th. The shares were purchased at an average cost of $68.39 per share, with a total value of $683,900.00. Following the completion of the acquisition, the chief executive officer directly owned 226,151 shares in the company, valued at $15,466,466.89. This trade represents a 4.63% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, COO Gerard H. Warner III acquired 1,450 shares of Cooper Companies stock in a transaction that occurred on Friday, September 5th. The stock was acquired at an average price of $69.23 per share, with a total value of $100,383.50. Following the completion of the acquisition, the chief operating officer directly owned 18,319 shares in the company, valued at $1,268,224.37. This represents a 8.60% increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders bought 17,975 shares of company stock worth $1,216,346. Insiders own 1.98% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on COO shares. The Goldman Sachs Group set a $64.00 target price on shares of Cooper Companies and gave the stock a “sell” rating in a report on Wednesday, October 1st. Wall Street Zen lowered Cooper Companies from a “buy” rating to a “hold” rating in a research report on Saturday, July 12th. BNP Paribas raised Cooper Companies from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, July 22nd. Needham & Company LLC reaffirmed a “buy” rating and issued a $94.00 price target on shares of Cooper Companies in a research note on Thursday, August 28th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Cooper Companies in a report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $84.77.

Cooper Companies Price Performance

COO stock opened at $74.45 on Thursday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 2.12. The firm has a 50 day moving average price of $69.65 and a 200-day moving average price of $73.22. The Cooper Companies, Inc. has a 52-week low of $61.78 and a 52-week high of $109.04. The firm has a market capitalization of $14.80 billion, a price-to-earnings ratio of 36.68, a PEG ratio of 1.97 and a beta of 1.02.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.07 by $0.03. The firm had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.06 billion. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.Cooper Companies’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Equities research analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies announced that its Board of Directors has initiated a share repurchase plan on Wednesday, September 17th that authorizes the company to buyback $2.00 billion in outstanding shares. This buyback authorization authorizes the medical device company to reacquire up to 15.4% of its shares through open market purchases. Shares buyback plans are generally an indication that the company’s leadership believes its stock is undervalued.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.